Lead toxicity remains a major health problem in the U.S. affecting 17% of all preschool children. Bone is its major reservoir. Although animal and bone cell studies have revealed significant insights into pb2+ toxicity, at the molecular level very little is known. Some of the properties of a noncollagenous protein secreted from the osteoblast, osteocalcin, have been found to be altered by Pb2+. Osteocalcin plays a role in bone mineralization as well as resorption. Structural features associated with its function are a Ca2+ dependent alpha-helical conformation in the region containing its 3 gamma- carboxyglutamic acid (Gla) residues which is necessary for enhanced binding to bone mineral, hydroxyapatite. An accessible COOH terminus is thought to be involved in promoting bone resorption. While Ca2+ promotes binding, Pb2+ has been found to inhibit the binding of osteocalcin to hydroxyapatite. The mechanism for this is unknown. Presently, no high resolution structures have been determined for Ca2+ or Pb2+ - osteocalcin complexes and very little in general is known about the effect of a toxic metal on structure and function relationships in proteins. The goal of this research is to further understand the mechanism of Pb2+ toxicity at the molecular level, in bone, by comparing precise structural and functional data of Ca2+ - and Pb2+ - osteocalcin.
The specific aims are to: 1) Determine whether Pb2+ effects the binding of osteocalcin to hydroxyapatite in-vitro and in mineralizing osteoblastic bone cells. 2) Elucidate a mechanism for the enhanced binding of Ca2+-osteocalcin to hydroxyapatite comparing the distances between the free side chain COOH groups, from the 2D NMR structure, to the known Ca2+ spacings in the hydroxyapatite crystal. 3) Elucidate a mechanism for the inhibitory effect of Pb2+ on osteocalcin binding to hydroxyapatite by contrasting the structure of Pb2+- osteocalcin to that of Ca2+-osteocalcin. 4) To determine and compare the structures of Ca2+- and Pb2+-osteocalcin using small amounts of human (2Gla) osteocalcin. 5) To investigate whether Pb2+ alters the role of osteocalcin as a regulator of mineralization. The results of this study should aid in elucidating a molecular mechanism for Pb2+ toxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29ES009032-03
Application #
2872339
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Kirshner, Annette G
Project Start
1997-02-10
Project End
2002-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Malashkevich, Vladimir N; Almo, Steven C; Dowd, Terry L (2013) X-ray crystal structure of bovine 3 Glu-osteocalcin. Biochemistry 52:8387-92
Kalmatsky, B D; Batir, Y; Bargiello, T A et al. (2012) Structural studies of N-terminal mutants of connexin 32 using (1)H NMR spectroscopy. Arch Biochem Biophys 526:1-8
Morrill, Gene A; Dowd, Terry L; Kostellow, Adele B et al. (2011) Progesterone-induced changes in the phosphoryl potential during the meiotic divisions in amphibian oocytes: role of Na/K-ATPase. BMC Dev Biol 11:67
Monir, A U; Gundberg, C M; Yagerman, S E et al. (2010) The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone 47:888-94